The Comparison of Quality of Life of Prolanis Participants with Type 2 Diabetes Mellitus Receiving Monotherapy and Polytherapy at Prambanan Public Health Center, Sleman. Journal of Pharmaceutical and Sciences, v. 8, n. 3, p. 1732–1739, 22 Aug.2025.